Precision Health funding for the Precision Opioid Prescribing Use Case has generated research, published in JAMA Network Open, that finds non-opioid pain medications do just as well (if not better), in treating most post-extraction pain.

This article originally appeared on the University of Michigan School of Dentistry website.

A new study about the use of opioids to control pain when teeth are extracted indicates other pain medications are just as effective or more so.

Co-author Romesh Nalliah, Associate Dean for Patient Services at the School of Dentistry, said the study indicates that the use of opioids by dentists can be drastically reduced or eliminated altogether.

Opioid addiction and overdoses have become a national epidemic in the last decade, leading to calls for healthcare providers to write fewer opioid prescriptions or use alternative pain medications, such as acetaminophen.

Nalliah, a Clinical Professor of Dentistry in the Department of Cariology, Restorative Sciences and Endodontics, worked on the study with co-author Dr. Chad Brummett, Director of the Division of Pain Research and of Clinical Research in the Department of Anesthesiology at Michigan Medicine, U-M’s academic medical center.

More than 325 dental patients who had teeth removed were asked to rate their pain and satisfaction. About half of the study’s patients who had surgical extraction and 39% who had routine extraction were prescribed opioids. Researchers compared the pain and satisfaction of those who used opioids to those who didn’t.

“I feel like the most important finding is that patient satisfaction with pain management was no different between the opioid group and non-opioid group, and it didn’t make a difference whether it was surgical or routine extraction,” Nalliah said.

The American Dental Association suggests limiting opioid prescribing to seven days’ supply, but Nalliah believes that’s too high. “I think we can almost eliminate opioid prescribing from dental practice. Of course, there are going to be some exceptions, like patients who can’t tolerate nonsteroidal anti-inflammatories,” he said. “I would estimate we can reduce opioid prescribing to about 10 percent of what we currently prescribe as a profession.”

The findings appear in JAMA Network Open. A summary of the study, along with an audio interview with Dr. Nalliah, was posted by the University of Michigan News Service.